Home › Funds › Deltroit Asset Management (UK) LLP › ABUS

Deltroit Asset Management (UK) LLP position in ABUS

ARBUTUS BIOPHARMA CORP · Health Care

Deltroit Asset Management (UK) LLP reported holding 1,200,000 shares of ABUS (ARBUTUS BIOPHARMA CORP) in its Q2 2026 13F filing — a position valued at US$5.8M, representing 0.89% of its reported portfolio and ranking #24 among its reported holdings. Deltroit Asset Management (UK) LLP has disclosed ABUS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.20M sh
Reported value held$5.76M
Portfolio Weight0.89%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deltroit Asset Management (UK) LLP's ABUS position evolved

Deltroit Asset Management (UK) LLP first disclosed a stake in ABUS in Q1 2026 at 800,000 shares (US$3.6M). The position peaked in Q2 2026 at 1,200,000 shares, worth US$5.8M. Across 2 filings, Deltroit Asset Management (UK) LLP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,200,000 shares valued at US$5.8M — an increase of 400,000 shares quarter over quarter.. Notable position changes include a 50% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 800.00K $3.60M New
Q2 2026 1.20M $5.76M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABUS and 13F data

ABUS (ARBUTUS BIOPHARMA CORP) is a Health Care company. 43 other funds we track also report a position in ABUS — the largest reported positions include Whitefort Capital Management, LP (US$75.8M), Two Seas Capital LP (US$38.9M), BlackBarn Capital Partners LP (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABUS

All ABUS fund holders →

FAQ

How long has Deltroit Asset Management (UK) LLP held ABUS?

Deltroit Asset Management (UK) LLP has disclosed ABUS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Deltroit Asset Management (UK) LLP's current position in ABUS?

As of Q2 2026, Deltroit Asset Management (UK) LLP holds 1.20M shares of ABUS (ARBUTUS BIOPHARMA CORP), valued at $5.76M, representing 0.89% of its reported portfolio and ranking #24.

Has Deltroit Asset Management (UK) LLP been buying or selling ABUS?

In the latest 13F filing (Q2 2026), Deltroit Asset Management (UK) LLP increased its position in ABUS. The position peaked in Q2 2026 at 1.20M shares.

Which other funds hold ABUS?

Other major institutional holders of ABUS include Whitefort Capital Management, LP, Two Seas Capital LP, BlackBarn Capital Partners LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.